We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

May 14, 2020

News You Need - 3 Big Little Things from HealthXL

Announcements/News
Sophie Madden
&

It’s time for your monthly digital health news dose. We have looked back at three of the most noteworthy pieces of news from the last month and distilled what they mean for the industry and the key takeaways you should have on your radar. Interested in getting beyond the headlines? We’ve included three industry experts who can help you get behind these stories - just let us know if you’d like us to make the introduction!

Busy hospitals are actually losing millions during this pandemic

Snapshot of the Story:

Hospitals have had financial issues for a long time now. COVID-19 has just exacerbated these. The American Hospital Association estimates losses for hospitals at $1 million a day. Specific numbers for these losses are difficult to obtain, but some institutions are now reporting their experience. Boston Medical Center is reporting losses of $5 million per week. Sarasota Memorial Health Care System reported a $16 million drop in revenue in March.

Why it’s notable:

  1. It's ironic that in the middle of a pandemic health care spending would be down.
  2. Many rural centers, independent surgeries are vacant due to a lack of COVID-19 cases, or any other cases. Some of these may never open again.
  3. Indicates the rising costs of basic medical supplies pre and post pandemic - not only are revenues haemorrhaging, but operational costs are going up as well. 

Industry Implications:

  1. Critical work force (healthcare practitioners)  may actually be laid off, or suffer from paycuts which seems a little counter intuitive given how necessary and important they are at this time, and will be after.
  2. A switch back to good old days of more brick and mortar consults, lots of elective procedures, etc once the tide has passed as telehealth will not make us as much money!
  3. While the pandemic has brought out the importance and need for digital health, hospitals are key stakeholders in investments and partnerships for the sustenance of these SMEs, and that is likely to suffer.


Steve Lindseth
Steve Lindseth
Digital Health Investor

Steve is a seasoned digital health investor and advisor to numerous Healthcare Provider Innovation groups. Connect with Steve to get his perspective on how hospitals can innovate and respond during this pandemic.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

The doctor will facetime you now – prospects of remote doctoring post-COVID

Snapshot of the Story:

This week the Federal Communications Commission’s (FCC) Wireline Competition Bureau approved an additional $4.2M in funding for 13 providers in the US. This is the fourth set of funding allocated the context of the FCC’s Telehealth Program since the pandemic took a hold, bringing total funding to date to $13.7 million for 30 health care providers across 16 states. The FCC has received a budget of $200 million to fund telehealth initiatives as part of the CARES Act in the US. 

Why it’s notable:

  1. The demand and use of telehealth services has quite literally exploded across the world. This uptake is providing tremendous opportunities for telehealth start-ups. 
  2. This week, for instance, Sweden-based telehealth company KRY launched a light touch version of its video consultation platform LIVI Connect in the US. Elsewhere, the company has seen the number of clinical consultations it usually provides more than double.
  3. It is fair to say that the adoption of telehealth has been mediocre at best prior to the virus outbreak, much of this a result of regulatory hurdles as well physician and patient scepticism. And yet today, we can’t help but wonder if telehealth is going to be an integral part of care in the post-COVID world. 

Industry Implications:

  1. Regulators across jurisdictions have had to show tremendous agility and flexibility to prevent a complete collapse of health care services, as a result of which GDPR and HIPAA have temporarily been thrown out the window. How much longer can privacy and confidentiality realistically be compromised for? In fact, the Central London Community Healthcare (CLCH) NHS trust recently banned the use of Zoom for remote video consultations following reports of ‘zoombombing’. 
  1. Many telehealth proponents are convinced telehealth is here to stay. Patients and providers convinced of the convenience of telehealth services are unlikely to want to relinquish this technology. 
  1. Pandemic-related regulatory exemptions and rollbacks are temporary – let’s hope they trigger a re-balancing of information governance facilitating greater health-tech adoption.

Read David Shaywitz' perspectives on COVID-19 here: https://www.astoundinghealthtech.com/covid-19-healthtech-insights

David Shaywitz
David Shaywitz
Founder
Astounding HealthTech

David is a physician and health tech expert. He recently founded Astounding Healthtech to help leaders work through the challenges of effectively leveraging emerging digital and data opportunities. Connect with David to get his perspective on how digital solutions are helping to solve challenges during the pandemic.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Contact tracing apps: a futile asset?

Snapshot of the Story

This week, a rare partnership between the two biggest tech powerhouses, Apple and Google, caught everyone’s attention. The two have come together to build an automated contact tracing framework for enhanced precision and range of their wireless Bluetooth protocols in an effort to assist national authorities with tracking people infected and those at risk of infection with SARS-CoV-2. Though very little details are known about this new system, the end-product will allow developers to build apps that work on both platforms. Together, Apple and Google command 3.5bn of the world’s computing and connected devices. 

Why it’s notable

  1. Ireland, America, Britain, Singapore, Germany have all built apps to enhance their contact tracing processes, with many more countries likely to follow suit. 
  2. Contact tracing apps rely on an exchange protocol between devices to securely communicate the infection status of device holders. This information is fed back to authorities and allows them to assess infection risks and notify individuals if required. 
  3. Despite overhauls planned by Apple and Google, app-based contact tracing systems rely on critical mass adoption. Experts contend that 60%-80% of smartphone users will need to install such apps, an unrealistic target at this stage. 

Industry implications

  1. If authorities want to get a true grip on the spread of the virus in their jurisdictions, contact tracing must go hand in hand with large-scale testing and so far we’re seeing massive discrepancies between countries.

  2. Perhaps an obvious one, but automatic contact tracing is not going to be of much use if there aren’t enough human resources to act on this information.

  3. Not to sound conspiratory, but authorities must be fully transparent about what kind of data is gathered and how it is processed (#coronopticon). Privacy concerns must be alleviated amidst an already severe curtailment of civil liberties.

  4. All bets are on tech these days, one way or another and we are tracking this! Check out our Covid-19 solutions map. We’ve recently added Health Beacon and many others to this map. Health Beacon is an Irish medical adherence company that recently expanded its offering to include 24/7 virtual care support, medication collection, medical waste collection and home monitoring with their smart sharps bin. This will remove the need for these at-risk patients to go to the pharmacy and reduce visits to the hospital.

Axel Heitmueller
Axel Heitmueller
Managing Director
Imperial College Health Partners

Axel is the Managing Director at Imperial College Health Partners. Connect with Axel to get his perspective on how the UK is coping with the pandemic, and their use of contact tracing apps.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

DTx last mile delivery - HCPs and patients adoption

2nd November @ 11:45AM EDT

Join us in this informal conversation where we will discuss the main challenges around HCP and Patient adoption of DTx. Apply now to connect with peers and learn from fellow thought leaders in this space.

Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Shrawan Patel
Shrawan Patel
Founder & MD, Strategy Health
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Tech Giants, Start-ups or Incumbents, who will disrupt healthcare?

4th November @ 11:30AM EDT

Join our Digital Health Meeting as discuss How do we define disruption in the healthcare industry? What is the ‘extinction event’ healthcare needs and why has it not happened yet? And what are the learnings from Tech Giants’ moves in healthcareApply now to join the conversation and share your thoughts on the topic.

Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software
Featuring
Amanda Goltz
Amanda Goltz
Principal, Business Development, Alexa Health & Wellness at Amazon
Conor Hayes
Conor Hayes
Healthcare Lead, Techvie Software

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Best routes to market for DTx in the EU

18th October @ 10:45AM EDT

Join us as we discuss the best routes to market for DTx in the EU. These 75 minute sessions are guaranteed to be filled with interesting debate and valuable insights, apply now to secure your place.

Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Featuring
Giuseppe Recchia
Giuseppe Recchia
Co-Founder & CEO, daVinci Digital Therapeutics
Nemanja Kovačev
Nemanja Kovačev
Digital Health Lead, Syrmia
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Companion DTx: clinical & economic evidence

20th October @ 10:45AM EDT

Join our Digital Health Meeting focused on Companion DTx: clinical and economic evidence. This informal conversation brings a variety of stakeholders together to discuss and share their thoughts and experiences around this topic.

Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
Featuring
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Céline Ulmann
Céline Ulmann
Head of R&D Digital, Almirall
AI in Healthcare
AI in Healthcare
AI in Healthcare
AI in Healthcare

Masterclass: AI-based diagnostics - learnings from a real-world use case

21st October @ 9:00AM GMT

In this masterclass, Zachary Tan (Advisor at CancerAid; Venture Creation Partner at Aegis Ventures; more info here) & Lisa Zhu (Research Fellow of the Center for Eye Research Australia) will walk us through the key learnings from their latest article in Scientific Reports (Nature) on real-world AI-based screening for diabetic retinopathy in Australia. This early-stage study is one of the first globally to describe the real-world implementation of AI in healthcare.

Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Featuring
Zachary Tan
Zachary Tan
Venture Creation Partner, Aegis Ventures
Lisa Zhu
Lisa Zhu
Research Fellow, CERA
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology
Digital Mental Health & Neurology

Digital Health in Mental Health: Commercialization Models

21st October @ 10:45AM EDT

Join us in this informal conversation where we will discuss the best commercialisation models for digital companies in the mental health space. Our 75 minute sessions are guaranteed to be filled with interesting debate and great conversation.

Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices
Featuring
Robert Garber
Robert Garber
Partner, 7Wire Ventures
Sarah Fisher
Sarah Fisher
Senior Director, Global Markets, External Innovation, Johnson & Johnson Medical Devices

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.